FR2253512B1 - - Google Patents

Info

Publication number
FR2253512B1
FR2253512B1 FR7439371A FR7439371A FR2253512B1 FR 2253512 B1 FR2253512 B1 FR 2253512B1 FR 7439371 A FR7439371 A FR 7439371A FR 7439371 A FR7439371 A FR 7439371A FR 2253512 B1 FR2253512 B1 FR 2253512B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7439371A
Other versions
FR2253512A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2360443A external-priority patent/DE2360443A1/de
Priority claimed from DE19742445161 external-priority patent/DE2445161A1/de
Application filed by Schering AG filed Critical Schering AG
Publication of FR2253512A1 publication Critical patent/FR2253512A1/fr
Application granted granted Critical
Publication of FR2253512B1 publication Critical patent/FR2253512B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
FR7439371A 1973-11-30 1974-12-02 Expired FR2253512B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2360443A DE2360443A1 (de) 1973-11-30 1973-11-30 D-homo-20-ketopregnane
DE19742445161 DE2445161A1 (de) 1974-09-19 1974-09-19 D-homo-20-ketopregnane ii

Publications (2)

Publication Number Publication Date
FR2253512A1 FR2253512A1 (fr) 1975-07-04
FR2253512B1 true FR2253512B1 (fr) 1978-02-03

Family

ID=25766200

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7439371A Expired FR2253512B1 (fr) 1973-11-30 1974-12-02

Country Status (14)

Country Link
US (1) US4045574A (fr)
JP (1) JPS5084561A (fr)
AT (1) AT347611B (fr)
CA (1) CA1030522A (fr)
CH (1) CH618183A5 (fr)
DD (1) DD115659A5 (fr)
DK (1) DK134348C (fr)
ES (1) ES432106A1 (fr)
FR (1) FR2253512B1 (fr)
GB (1) GB1494097A (fr)
IE (1) IE40423B1 (fr)
IL (1) IL46153A (fr)
NL (1) NL7415577A (fr)
SE (1) SE408426B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879316A (en) * 1987-02-26 1989-11-07 The University Of Tennessee Research Corporation Interpenetrating polymer network ion exchange membranes and method for preparing same
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
WO2004016640A2 (fr) * 2002-08-16 2004-02-26 Pharmacia & Upjohn Company Llc Intermediaires de 5 androstene-3?-ol steroides et leurs procedes de preparation
US20070066579A1 (en) * 2002-08-16 2007-03-22 White Michael J 5-androsten-3beta-ol steroid intermediates and processs for their preparation
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
HUE051403T2 (hu) 2013-04-17 2021-03-01 Sage Therapeutics Inc Neuroaktív 19-nor-szteroidok kezelési eljárásokhoz
KR20230172622A (ko) 2013-04-17 2023-12-22 세이지 테라퓨틱스, 인크. 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법
WO2014169836A1 (fr) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor-stéroïdes neuroactifs et procédés d'utilisation de ceux-ci
PT3021852T (pt) 2013-07-19 2021-04-21 Sage Therapeutics Inc Esteroides neuroativos, composições e utilizações das mesmas
CA2921512A1 (fr) 2013-08-23 2015-02-26 Sage Therapeutics, Inc. Steroides neuroactifs, compositions et utilisations
WO2015195962A1 (fr) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Stéroïdes neuroactifs, leurs compositions et utilisations
HUE051488T2 (hu) 2014-10-16 2021-03-01 Sage Therapeutics Inc Készítmények és eljárások központi idegrendszeri rendellenességek kezelésére
US10577390B2 (en) 2014-10-16 2020-03-03 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
EP3719029A1 (fr) 2014-11-27 2020-10-07 Sage Therapeutics, Inc. Compositions pour l'induction de la sédation
DK3250210T3 (da) 2015-01-26 2021-03-08 Sage Therapeutics Inc Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
US10329320B2 (en) 2015-02-20 2019-06-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
RU2019103590A (ru) 2016-07-11 2021-02-11 Сейдж Терапьютикс, Инк. С17-, с20- и с21-замещенные нейроактивные стероиды и способы их применения
MA51316A (fr) * 2017-12-22 2020-10-28 Sage Therapeutics Inc Compositions et méthodes permettant de traiter les troubles du snc
TW202039528A (zh) 2018-12-05 2020-11-01 美商賽吉醫療公司 神經活性類固醇及其使用方法
JP2022534424A (ja) 2019-05-31 2022-07-29 セージ セラピューティクス， インコーポレイテッド 神経刺激性ステロイド及びその組成物
AU2020304679A1 (en) * 2019-06-27 2022-01-20 Sage Therapeutics, Inc. Compounds for treating CNS disorders
WO2020264495A1 (fr) * 2019-06-27 2020-12-30 Sage Therapeutics, Inc. Compositions et méthodes de traitement de troubles du système nerveux central

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2860158A (en) * 1954-10-18 1958-11-11 Sterling Drug Inc Compounds of the perhydrochrysene series and preparation thereof
US3686223A (en) * 1968-12-26 1972-08-22 Sterling Drug Inc D-homoestratrienes
US3833621A (en) * 1972-03-20 1974-09-03 Richardson Merrell Inc 3-keto-7(alpha,beta)-loweralkyl-delta5 steroids and process for preparing same

Also Published As

Publication number Publication date
CA1030522A (fr) 1978-05-02
DK134348C (da) 1977-03-21
IL46153A0 (en) 1975-02-10
DD115659A5 (fr) 1975-10-12
ATA950774A (de) 1978-05-15
GB1494097A (en) 1977-12-07
DK134348B (da) 1976-10-25
ES432106A1 (es) 1976-11-01
IE40423L (en) 1975-05-30
AT347611B (de) 1979-01-10
SE7414960L (fr) 1975-06-02
IE40423B1 (en) 1979-05-23
NL7415577A (nl) 1975-06-03
FR2253512A1 (fr) 1975-07-04
AU7586774A (en) 1976-06-03
JPS5084561A (fr) 1975-07-08
CH618183A5 (fr) 1980-07-15
DK604174A (fr) 1975-07-28
SE408426B (sv) 1979-06-11
US4045574A (en) 1977-08-30
IL46153A (en) 1979-01-31

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU465372B2 (fr)
AR201235Q (fr)
AR201231Q (fr)
AU474593B2 (fr)
FR2253512B1 (fr)
AU474838B2 (fr)
AU465453B2 (fr)
AU471343B2 (fr)
AU465434B2 (fr)
AU450229B2 (fr)
AR201229Q (fr)
AU466283B2 (fr)
AU476696B2 (fr)
AU472848B2 (fr)
AR197627A1 (fr)
AR200885A1 (fr)
AR200256A1 (fr)
AR193950A1 (fr)
AR196382A1 (fr)
AR195311A1 (fr)
AU461342B2 (fr)
AR201432A1 (fr)
AR210729A1 (fr)
AR195948A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse